A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in ...

A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell ...

Patients using GLP-1 RAs may experience dermatologic adverse side effects, including skin laxity, hair shedding, and facial ...

Patients with difficult to manage or treatment-refractory axial spondyloarthritis may benefit from a tailored therapeutic approach.

Clinical deep remission in rheumatoid arthritis is linked to sustained disease control and may identify patients who can safely taper medications.

The American Heart Association issued a scientific statement on the role of physical activity in obesity treatment and cardiometabolic health.

Experts told Newsweek there are several symptoms people often dismiss without realizing what they could be pointing to.

Melatonin, the sleep aid tucked into many medicine cabinets, may also have a place in chronic pain care. A new analysis from ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Quantified preferences favored higher lesion growth rate reduction (10%→50% at 18 months) as the primary driver across all ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...